Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.69% |
| 2 | Technology | 12.68% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Lam Research
LRCX
$337B
| $5.61M | 0.01% |
411,740
-2,422,000
| -85% | -$34.7M |
|
1502
PTC Therapeutics
PTCT
$6.25B
| $5.61M | 0.01% |
163,311
-184,434
| -53% | -$6.63M |
|
1503
Grand Canyon Education
LOPE
$3.99B
| $5.6M | 0.01% |
58,277
-153,951
| -73% | -$17.9M |
|
|
FSCT
1504
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $5.58M | 0.01% |
214,634
+103,189
| +93% | +$2.86M |
|
|
REGI
1505
DELISTED
Renewable Energy Group, Inc.
REGI
| $5.57M | 0.01% |
216,898
-205,287
| -49% | -$5.55M |
|
1506
Invesco QQQ Trust
QQQ
$445B
| $5.57M | 0.01% |
36,129
-74,603
| -67% | -$12.5M |
|
|
ITG
1507
DELISTED
Investment Technology Group Inc
ITG
| $5.57M | 0.01% |
184,165
+62,931
| +52% | +$1.8M |
|
1508
BCE
BCE
$20.3B
| $5.57M | 0.01% |
140,821
-404,555
| -74% | -$16.6M |
|
|
WBK
1509
DELISTED
Westpac Banking Corporation
WBK
| $5.57M | 0.01% |
+318,666
| New | +$5.92M |
|
1510
CALL
Expedia Group
EXPE
$35.5B
| $5.57M | 0.01% |
49,400
+41,600
| +533% | +$4.98M |
|
1511
PUT
Trane Technologies
TT
$104B
| $5.57M | 0.01% |
+61,000
| New | +$6M |
|
|
LM
1512
DELISTED
Legg Mason, Inc.
LM
| $5.54M | 0.01% |
217,102
-177,892
| -45% | -$4.98M |
|
1513
Sensata Technologies
ST
$6.8B
| $5.52M | 0.01% |
123,143
+71,867
| +140% | +$3.25M |
|
1514
Texas Roadhouse
TXRH
$13.5B
| $5.51M | 0.01% |
92,367
+35,188
| +62% | +$2.26M |
|
1515
BOK Financial
BOKF
$8.65B
| $5.5M | 0.01% |
74,930
+71,230
| +1,925% | +$6.04M |
|
|
SCG
1516
CALL
DELISTED
Scana
SCG
| $5.5M | 0.01% |
+115,000
| New | +$4.94M |
|
|
SCG
1517
PUT
DELISTED
Scana
SCG
| $5.5M | 0.01% |
+115,000
| New | +$4.94M |
|
|
KNL
1518
DELISTED
Knoll, Inc.
KNL
| $5.49M | 0.01% |
333,336
+139,144
| +72% | +$2.72M |
|
1519
CALL
Stryker
SYK
$133B
| $5.49M | 0.01% |
35,000
+5,000
| +17% | +$836K |
|
1520
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
| $5.48M | 0.01% |
107,948
+92,448
| +596% | +$5.02M |
|
1521
PUT
T-Mobile US
TMUS
$196B
| $5.46M | 0.01% |
+85,900
| New | +$5.76M |
|
1522
Aldeyra Therapeutics
ALDX
$95.3M
| $5.46M | 0.01% |
657,976
-289,249
| -31% | -$2.96M |
|
|
NAVG
1523
DELISTED
Navigators Group Inc
NAVG
| $5.45M | 0.01% |
78,425
-187,455
| -71% | -$13M |
|
|
IMGN
1524
CALL
DELISTED
Immunogen Inc
IMGN
| $5.43M | 0.01% |
+1,131,100
| New | +$6.86M |
|
1525
Pediatrix Medical
MD
$2.21B
| $5.43M | 0.01% |
164,481
-986,332
| -86% | -$39.7M |
|
Similar funds
Millennium Management's Q4 2018 Portfolio in Review
As of Q4 2018, Millennium Management held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Athenahealth, Inc. worth $135M.
- Millennium Management's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Millennium Management added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Millennium Management's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Millennium Management fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Millennium Management's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Millennium Management opened 702 new positions and closed 844 in Q4 2018.
- Millennium Management's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.